These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 25804672

  • 1. Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.
    Olfat M, Silverman ED, Levy DM.
    Lupus; 2015 Aug; 24(9):966-72. PubMed ID: 25804672
    [Abstract] [Full Text] [Related]

  • 2. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
    Kumar S, Benseler SM, Kirby-Allen M, Silverman ED.
    Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.
    Serris A, Amoura Z, Canouï-Poitrine F, Terrier B, Hachulla E, Costedoat-Chalumeau N, Papo T, Lambotte O, Saadoun D, Hié M, Blanche P, Lioger B, Gottenberg JE, Godeau B, Michel M.
    Am J Hematol; 2018 Mar; 93(3):424-429. PubMed ID: 29247540
    [Abstract] [Full Text] [Related]

  • 4. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
    Shanafelt TD, Madueme HL, Wolf RC, Tefferi A.
    Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
    [Abstract] [Full Text] [Related]

  • 5. Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long-term follow-up and review of the literature.
    Jovancevic B, Lindholm C, Pullerits R.
    Lupus; 2013 Jun; 22(7):664-74. PubMed ID: 23612795
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and Safety of Rituximab in Systemic Lupus Erythematosus and Sjögren Syndrome Patients With Refractory Thrombocytopenia: A Retrospective Study of 21 Cases.
    Jiang B, Li T, Guo L, Shen H, Ye S, Chen S.
    J Clin Rheumatol; 2015 Aug; 21(5):244-50. PubMed ID: 26203828
    [Abstract] [Full Text] [Related]

  • 7. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
    Lindholm C, Börjesson-Asp K, Zendjanchi K, Sundqvist AC, Tarkowski A, Bokarewa M.
    J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
    [Abstract] [Full Text] [Related]

  • 8. Impact of autoimmune cytopenias on severity of childhood-onset systemic lupus erythematosus: A single-center retrospective cohort study.
    Ogbu EA, Chandrakasan S, Rouster-Stevens K, Greenbaum LA, Sanz I, Gillespie SE, Marion C, Okeson K, Prahalad S.
    Lupus; 2021 Jan; 30(1):109-117. PubMed ID: 33108953
    [Abstract] [Full Text] [Related]

  • 9. Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 16 cases.
    Dufour JF, Pradat P, Ruivard M, Hot A, Dumontet C, Broussolle C, Trepo C, Sève P.
    Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):245-53. PubMed ID: 19279468
    [Abstract] [Full Text] [Related]

  • 10. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
    Dierickx D, Verhoef G, Van Hoof A, Mineur P, Roest A, Triffet A, Kentos A, Pierre P, Boulet D, Bries G, Lê PQ, Janssens A, Delannoy A.
    J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
    [Abstract] [Full Text] [Related]

  • 11. Autoimmune hemolytic anemia in systemic lupus erythematosus at diagnosis: differences between pediatric and adult patients.
    Gormezano NW, Kern D, Pereira OL, Esteves GC, Sallum AM, Aikawa NE, Pereira RM, Silva CA, Bonfá E.
    Lupus; 2017 Apr; 26(4):426-430. PubMed ID: 27821514
    [Abstract] [Full Text] [Related]

  • 12. Use of rituximab in the treatment of refractory systemic lupus erythematosus: Singapore experience.
    Lateef A, Lahiri M, Teng GG, Vasoo S.
    Lupus; 2010 May; 19(6):765-70. PubMed ID: 20118162
    [Abstract] [Full Text] [Related]

  • 13. Successful rituximab treatment of refractory hemophagocytic lymphohistiocytosis and autoimmune hemolytic anemia associated with systemic lupus erythematosus.
    So MW, Koo BS, Kim YJ, Kim YG, Lee CK, Yoo B.
    Mod Rheumatol; 2014 Sep; 24(5):855-7. PubMed ID: 24517558
    [Abstract] [Full Text] [Related]

  • 14. Association of Rituximab Use With Adverse Events in Children, Adolescents, and Young Adults.
    McAtee CL, Lubega J, Underbrink K, Curry K, Msaouel P, Barrow M, Muscal E, Lotze T, Srivaths P, Forbes LR, Allen C, Bernhardt MB.
    JAMA Netw Open; 2021 Feb 01; 4(2):e2036321. PubMed ID: 33533931
    [Abstract] [Full Text] [Related]

  • 15. Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment.
    Smith KG, Jones RB, Burns SM, Jayne DR.
    Arthritis Rheum; 2006 Sep 01; 54(9):2970-82. PubMed ID: 16947528
    [Abstract] [Full Text] [Related]

  • 16. Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus.
    Perrotta S, Locatelli F, La Manna A, Cennamo L, De Stefano P, Nobili B.
    Br J Haematol; 2002 Feb 01; 116(2):465-7. PubMed ID: 11841453
    [Abstract] [Full Text] [Related]

  • 17. Rituximab therapy for childhood-onset systemic lupus erythematosus.
    Willems M, Haddad E, Niaudet P, Koné-Paut I, Bensman A, Cochat P, Deschênes G, Fakhouri F, Leblanc T, Llanas B, Loirat C, Pillet P, Ranchin B, Salomon R, Ulinski T, Bader-Meunier B, French Pediatric-Onset SLE Study Group.
    J Pediatr; 2006 May 01; 148(5):623-627. PubMed ID: 16737873
    [Abstract] [Full Text] [Related]

  • 18. Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab.
    Tokunaga M, Fujii K, Saito K, Nakayamada S, Tsujimura S, Nawata M, Tanaka Y.
    Rheumatology (Oxford); 2005 Feb 01; 44(2):176-82. PubMed ID: 15494350
    [Abstract] [Full Text] [Related]

  • 19. Current role of rituximab in systemic lupus erythematosus.
    Mok CC.
    Int J Rheum Dis; 2015 Feb 01; 18(2):154-63. PubMed ID: 25522652
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of rituximab in childhood-onset systemic lupus erythematosus and other rheumatic diseases.
    Tambralli A, Beukelman T, Cron RQ, Stoll ML.
    J Rheumatol; 2015 Mar 01; 42(3):541-6. PubMed ID: 25593242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.